Viewing Study NCT07058103


Ignite Creation Date: 2025-12-24 @ 7:45 PM
Ignite Modification Date: 2026-04-02 @ 3:54 AM
Study NCT ID: NCT07058103
Status: RECRUITING
Last Update Posted: 2025-07-10
First Post: 2025-06-10
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Tislelizumab , Cyclophosphamide, Mitoxantrone Liposomes, Chidamide, and Prednisone in the Treatment of R/R AITL
Sponsor: The Affiliated Hospital of Xuzhou Medical University
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Angioimmunoblastic T-Cell Lymphoma Recurrent View
None Angioimmunoblastic T-Cell Lymphoma Refractory View
Keywords: